Trademark: 78277322
Word
ETHICA
Status
Registered
Status Code
800
Status Date
Thursday, February 23, 2017
Serial Number
78277322
Registration Number
3188634
Registration Date
Tuesday, December 26, 2006
Mark Type
1000
Filing Date
Tuesday, July 22, 2003
Published for Opposition
Tuesday, October 10, 2006

Trademark Owner History

Classifications
41 Study specific clinical personnel training programs for investigators, coordinators and investigator meetings; conducting investigator meetings
35 Clinical trial supplies management services, namely-customized drug packaging and labeling, central and site administered randomization and study supply distribution; developing and managing distribution and storage logistics for all clinical supplies, namely study drugs and devices, case report forms, study binders and all study related documentation; clinical trial management services, namely-pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, close-out visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labeling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; managing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; managing the development of all study related documents and materials, namely study protocols, amendments, paper and electronic case report forms, and informed consent forms; managing study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters; management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; managing all aspects of study drug reconciliation and inventory and distribution reports; managing all aspects of clinical trials, namely managing investigators, technicians, and participants, ethical reviews, investigator meetings, databases, statistical analyses and reporting, randomization logistics, medical writing services; recruitment of investigators, technicians and participants; providing strategies for recruitment of participants
42 Research services for clinical trials for others, namely conducting an ethical review of projects to protect the rights and welfare of research participants, developing study protocols, designing case report forms, developing participant screening tools, namely general and medical questionnaires, developing complete databases in accordance with strict guidelines, tracking of study parameters, providing statistical analyses, reporting and developing tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries and adverse events; developing and implementing randomization logistics, namely randomization envelopes, customized blind-breakable drug labeling, code break management and reports, manufacturing of subject-and protocol-specific kits using bulk oral and topical medications; medical writing services, namely-drafting clinical study protocols, amendments, case report forms, informed consent forms, statistical analysis plans, full integrated clinical research reports, publications, abstracts and manuscript; developing site and study-specific subject recruitment strategies and programs, namely contingency strategies and solutions to address specific project challenges; developing study operations and monitoring manuals in accordance with data management conventions, web-based data listings, namely adverse events, enrollment status, efficacy endpoints and paper and electronic study newsletters

Trademark Events
Sep 20, 2023
Automatic Update Of Assignment Of Ownership
Feb 23, 2017
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Feb 23, 2017
Registered And Renewed (First Renewal - 10 Yrs)
Feb 23, 2017
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Feb 23, 2017
Case Assigned To Post Registration Paralegal
Dec 22, 2016
Teas Section 8 & 9 Received
Dec 26, 2015
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jan 16, 2013
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 15, 2013
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 15, 2013
Case Assigned To Post Registration Paralegal
Dec 20, 2012
Teas Section 8 & 15 Received
Nov 23, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 23, 2009
Teas Change Of Owner Address Received
Jan 29, 2007
Exparte Appeal Terminated
Dec 26, 2006
Registered-Principal Register
Oct 10, 2006
Published For Opposition
Sep 20, 2006
Notice Of Publication
Aug 18, 2006
Law Office Publication Review Completed
Aug 11, 2006
Assigned To Lie
Aug 1, 2006
Approved For Pub - Principal Register
Jul 12, 2006
Teas/Email Correspondence Entered
Jun 13, 2006
Correspondence Received In Law Office
Jun 13, 2006
Teas Response To Office Action Received
May 15, 2006
Examiner's Amendment/Priority Action E-Mailed
May 15, 2006
Examiners Amendment And/Or Priority Action - Completed
Feb 15, 2006
Action Denying Req For Recon E-Mailed
Feb 15, 2006
Action Continuing Final - Completed
Dec 28, 2005
Ex Parte Appeal-Instituted
Dec 28, 2005
Jurisdiction Restored To Examining Attorney
Dec 22, 2005
Exparte Appeal Received At Ttab
Dec 21, 2005
Teas/Email Correspondence Entered
Dec 13, 2005
Correspondence Received In Law Office
Dec 13, 2005
Teas Response To Office Action Received
Jun 13, 2005
Final Refusal E-Mailed
Jun 13, 2005
Final Refusal Written
May 20, 2005
Use Amendment Accepted
May 18, 2005
Amendment From Applicant Entered
Apr 29, 2005
Correspondence Received In Law Office
Apr 29, 2005
Fax Received
Apr 11, 2005
Inquiry To Suspension E-Mailed
Apr 11, 2005
Suspension Inquiry Written
Mar 10, 2005
Suspension Checked ¿ To Attorney For Action
Sep 9, 2004
Letter Of Suspension E-Mailed
Sep 9, 2004
Suspension Letter Written
Aug 12, 2004
Amendment From Applicant Entered
Jul 30, 2004
Correspondence Received In Law Office
Aug 12, 2004
Assigned To Lie
Aug 9, 2004
Amendment From Applicant Entered
Jul 26, 2004
Correspondence Received In Law Office
Aug 9, 2004
Assigned To Lie
Jul 30, 2004
Paper Received
Jan 27, 2004
Non-Final Action E-Mailed
Jan 12, 2004
Assigned To Examiner
Sep 17, 2003
Amendment To Use Processing Complete
Sep 10, 2003
Use Amendment Filed
Sep 10, 2003
Teas Amendment Of Use Received

Trademark Alertz updated from USPTO on 2030-01-24